US 11851443
Neprilysin inhibitors
granted A61KA61K31/42A61K31/422
Quick answer
US patent 11851443 (Neprilysin inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/42, A61K31/422, A61K31/5377, A61K45/06